WEBINAR ON DEMAND
Duration: 1 hour

​Technological developments have unlocked enormous potential in the world of preclinical drug development, but the industry is struggling to take full advantage of these new possibilities. Drug development pipelines can still take years or even decades, along with millions of dollars of investment, with no guarantee of success or return on investment. New technologies provide mountains of new data, but human scientists simply aren’t capable of handling that volume of data in an efficient way. 

In this webinar, drug discovery experts Imran Khan (Bristol Myers Squibb) and Jorge Garcia Fortanet (DEM Biopharma) join AI expert Jim Corson (Enthought) to discuss: 

• Some of the challenges currently facing pharmaceutical research, including target validation, an overwhelming amount of data, and inefficient processes
• How AI can work in partnership with scientists to provide predictions, modeling and simulations beyond human capabilities 
• Why there is urgency to take advantage of AI and machine learning now to avoid losing out to the competition

SPEAKERS

Jim Corson, Ph.D.
Vice President of the Life Sciences Solutions Group
Enthought

Imran Khan, Ph.D
Senior Scientist
Bristol Myers Squibb (BMS)

Jorge Garcia Fortanet, Ph. D
VP
DEM BioPharma